JP2025516566A5 - - Google Patents
Info
- Publication number
- JP2025516566A5 JP2025516566A5 JP2024566275A JP2024566275A JP2025516566A5 JP 2025516566 A5 JP2025516566 A5 JP 2025516566A5 JP 2024566275 A JP2024566275 A JP 2024566275A JP 2024566275 A JP2024566275 A JP 2024566275A JP 2025516566 A5 JP2025516566 A5 JP 2025516566A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- substituted
- groups
- indole
- alkyl groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB202206759 | 2022-05-09 | ||
| GB2206759.9 | 2022-05-09 | ||
| PCT/EP2023/062242 WO2023217764A1 (en) | 2022-05-09 | 2023-05-09 | Nox inhibitors for use in the treatment of alport syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025516566A JP2025516566A (ja) | 2025-05-30 |
| JP2025516566A5 true JP2025516566A5 (cg-RX-API-DMAC7.html) | 2026-05-18 |
Family
ID=86497898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024566275A Pending JP2025516566A (ja) | 2022-05-09 | 2023-05-09 | アルポート症候群の治療における使用のためのnox阻害剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20260021079A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4522162A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025516566A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250008750A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119212698A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023267259A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3252551A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL316732A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024013727A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202413355A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023217764A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2166010A1 (en) | 2008-09-23 | 2010-03-24 | Genkyo Tex Sa | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| UA116639C2 (uk) * | 2012-10-09 | 2018-04-25 | Рег'Юлес Терап'Ютікс Інк. | Способи лікування синдрому альпорта |
| CN107743483B (zh) | 2015-06-22 | 2022-01-28 | 埃科特莱茵药品有限公司 | Nadph氧化酶4抑制剂 |
| WO2017192304A1 (en) | 2016-05-02 | 2017-11-09 | Inception 1, Inc. | Arylcarboxamides and uses thereof |
| BR112019023109A2 (pt) | 2017-05-04 | 2020-05-26 | Glenmark Pharmaceuticals S.A. | Composto, composição farmacêutica e método para tratar uma doença, distúrbio, síndrome ou afecção mediada por nadph oxidase em um indivíduo |
| CN112384497A (zh) | 2018-05-09 | 2021-02-19 | 格卢科克斯生物科技有限公司 | 具有选择性nox抑制活性的新型磺酰胺衍生物 |
| CN114728168B (zh) * | 2019-11-15 | 2024-04-09 | 吉利德科学公司 | 三唑氨基甲酸酯吡啶基磺酰胺作为lpa受体拮抗剂及其用途 |
-
2023
- 2023-05-09 CA CA3252551A patent/CA3252551A1/en active Pending
- 2023-05-09 KR KR1020247038273A patent/KR20250008750A/ko active Pending
- 2023-05-09 WO PCT/EP2023/062242 patent/WO2023217764A1/en not_active Ceased
- 2023-05-09 EP EP23725687.0A patent/EP4522162A1/en active Pending
- 2023-05-09 JP JP2024566275A patent/JP2025516566A/ja active Pending
- 2023-05-09 TW TW112117178A patent/TW202413355A/zh unknown
- 2023-05-09 AU AU2023267259A patent/AU2023267259A1/en active Pending
- 2023-05-09 IL IL316732A patent/IL316732A/en unknown
- 2023-05-09 CN CN202380039063.5A patent/CN119212698A/zh active Pending
- 2023-05-09 US US18/863,495 patent/US20260021079A1/en active Pending
-
2024
- 2024-11-06 MX MX2024013727A patent/MX2024013727A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2005117383A (ru) | Производные фенилаланина в качестве ингибиторов дипептидилпептидазы для лечения или профилактики диабета | |
| US11591336B2 (en) | Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors | |
| RU2424242C2 (ru) | Азолопиримидины в качестве ингибиторов активности каннабиноидного рецептора 1 | |
| JP2004531473A5 (cg-RX-API-DMAC7.html) | ||
| JP2023513241A5 (cg-RX-API-DMAC7.html) | ||
| RU2015129538A (ru) | Замещенные имидазопиридины в качестве ингибиторов hdm2 | |
| JP2019535664A5 (cg-RX-API-DMAC7.html) | ||
| RU2017134901A (ru) | Соединения 1-циано-пирролидинов в качестве ингибиторов USP30 | |
| IL277579B (en) | Piperidinone derivatives as mdm2 inhibitors for cancer therapy | |
| JP2015522002A5 (cg-RX-API-DMAC7.html) | ||
| RU2018123779A (ru) | Новые соединения | |
| JP2007510689A5 (cg-RX-API-DMAC7.html) | ||
| JP2023525762A5 (cg-RX-API-DMAC7.html) | ||
| JP2015510938A5 (cg-RX-API-DMAC7.html) | ||
| JP2013508404A5 (cg-RX-API-DMAC7.html) | ||
| RU2008145504A (ru) | Новое соединение пиперазина и его применение в качестве ингибитора hcv полимеразы | |
| WO2019089835A1 (en) | Diazanaphthalen-3-yl carboxamides and preparation and use thereof | |
| EP2594270A2 (en) | The use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc) | |
| CA2571627A1 (en) | Substituted aryl-amine derivatives and methods of use | |
| JP2010535799A5 (cg-RX-API-DMAC7.html) | ||
| JP2014511355A5 (cg-RX-API-DMAC7.html) | ||
| RU2009105829A (ru) | СОЕДИНЕНИЯ И КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ ITPKb | |
| JP2021501216A5 (cg-RX-API-DMAC7.html) | ||
| IL310330A (en) | Compounds for the treatment of pain, in particular neuropathic pain, and/or other diseases or disorders that are associated with at2r and/or at2r mediated signaling | |
| KR20250081951A (ko) | 금속 채널 활성화제를 포함하는 병용 요법 |